Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Mol Cell Cardiol. 2013 Jun 10;62:189–202. doi: 10.1016/j.yjmcc.2013.05.021

Figure 7. A caged IRL2500 analog inhibits rhodamine-ET-3 binding in isolated nuclei and the increase in [Ca2+]n induced by caged ET-1.

Figure 7

A) Nuclei freshly isolated from rat ventricular myocytes were plated onto a laminin-coated Fluorodish and preincubated for 30 min with photolysed (uIRL2500) or not photolysed (cIRL2500) caged IRL2500 (10−6 M). Rhodamine ET-3 (7.5 × 10−9 M) was then added for an additional 30 min incubation. Following three washes, nuclei were stained with fluorescent DNA dye, DRAQ5. Images were acquired using a Zeiss LSM 710 microscope. Scale Bar = 4.8 μm. B) Changes in nucleoplasmic [Ca2+] were recorded, as described in Materials and Methods, before and after photolysis in cells preincubated with or without caged ET-1 (cET-1) and in presence or absence of caged IRL2500 (cIRL2500). DRAQ5 was used to target a region corresponding to the nucleoplasm. Signals are presented as background-subtracted normalized fluorescence (%F/F0), where F is the fluorescence intensity, and F0 is the resting fluorescence recorded in the same cell under steady-state conditions prior to photolysis. For each condition, the mean ± s.e.m. of nucleoplasmic Fluo-4 fluorescence at 50 s is presented.